More about

Prednisolone

News
December 06, 2024
2 min watch
Save

VIDEO: ‘Highly treatable’ IgG4-related disease ‘rewarding’ to diagnose

VIDEO: ‘Highly treatable’ IgG4-related disease ‘rewarding’ to diagnose

In this video, John H. Stone, MD, MPH, professor of medicine at Harvard Medical School, the Edward A. Fox Chair in Medicine at Massachusetts General Hospital, discusses an important facet of IgG4-related disease other rheumatologists and providers should be aware of.

News
December 03, 2024
2 min read
Save

Benralizumab for eosinophilic asthma/COPD exacerbations ‘could be a game-changer’

Benralizumab for eosinophilic asthma/COPD exacerbations ‘could be a game-changer’

Receiving a benralizumab injection during an acute asthma or COPD exacerbation with a blood eosinophil count of at least 300 cells/µL led to fewertreatment failures, according to results published in The Lancet Respiratory Medicine.

News
November 25, 2024
2 min read
Save

My anti-inflammatory drug regimen

My anti-inflammatory drug regimen

The goals of postoperative anti-inflammatory medications are to reduce pain, discomfort and inflammation and to prevent cystoid macular edema and prolonged or rebound iridocyclitis following cataract surgery.

Clinical Guidance
Rheumatoid Arthritis
Treatment Options

Corticosteroid Therapy

John J. Cush, MD; Michael E. Weinblatt, MD; Arthur Kavanaugh, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

News
September 19, 2023
2 min read
Save

Efficacy, safety outcomes similar with high, low prednisolone dose for sarcoidosis

Efficacy, safety outcomes similar with high, low prednisolone dose for sarcoidosis

Patients with sarcoidosis receiving 40 mg per day of prednisolone had comparable rates of treatment failure and adverse effects to patients receiving 20 mg per day, according to a European Respiratory Society International Congress presentation.

News
July 03, 2023
2 min read
Save

Mycophenolate mofetil induces remission in nearly 60% with autoimmune hepatitis

Mycophenolate mofetil induces remission in nearly 60% with autoimmune hepatitis

Mycophenolate mofetil was superior to azathioprine in achieving biochemical remission in treatment-naive patients with autoimmune hepatitis who were also treated with prednisolone, according to data presented at EASL Congress.

News
September 07, 2022
1 min read
Save

Point-of-care eosinophil-guided prednisolone for COPD exacerbations safe: STARR2 trial

Point-of-care eosinophil-guided prednisolone for COPD exacerbations safe: STARR2 trial

Personalized point-of-care eosinophil-guided oral prednisolone therapy in primary care was safe and did not worsen outcomes in individuals with COPD exacerbations, researchers reported at the European Respiratory Society International Congress.

News
July 13, 2022
2 min read
Save

Low-dose prednisolone beneficial in patients with established rheumatoid arthritis

Low-dose prednisolone beneficial in patients with established rheumatoid arthritis

Add-on low-dose prednisolone improves long-term disease activity and progression in senior patients with established rheumatoid arthritis, albeit with an increase in non-severe adverse events, according to data.

News
November 11, 2021
2 min read
Save

Extended initial prednisolone therapy did not alter nephrotic syndrome course in children

Prolonged initial prednisolone therapy does not significantly alter the disease course in young children with nephrotic syndrome, according to a speaker at ASN Kidney Week.

News
October 19, 2021
6 min watch
Save

VIDEO: Addition of abiraterone improves overall survival in two prostate cancer studies

VIDEO: Addition of abiraterone improves overall survival in two prostate cancer studies

In this video, Ben Tran, MD, discusses the PEACE-1 and STAMPEDE studies that looked at the addition of abiraterone acetate plus prednisolone (AAP) to standard therapy, which was found to improve survival vs. standard therapy.

View more